PBRM1-BD2-IN-2
Modify Date: 2024-02-27 12:08:48
PBRM1-BD2-IN-2 structure
|
Common Name | PBRM1-BD2-IN-2 | ||
|---|---|---|---|---|
| CAS Number | 2819989-57-4 | Molecular Weight | 311.14 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H9Cl2FN2O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PBRM1-BD2-IN-2PBRM1-BD2-IN-2 is a selective and cell-active polybromo-1 (PBRM1) bromodomain inhibitor. PBRM1-BD2-IN-2 has binding affinity and inhibitory activity for PBRM1-BD2 with Kd and IC50 values of 9.3 μM and 1.0 μM, respectively. PBRM1-BD2-IN-2 can be used for the research of cancer[1]. |
| Name | PBRM1-BD2-IN-2 |
|---|
| Description | PBRM1-BD2-IN-2 is a selective and cell-active polybromo-1 (PBRM1) bromodomain inhibitor. PBRM1-BD2-IN-2 has binding affinity and inhibitory activity for PBRM1-BD2 with Kd and IC50 values of 9.3 μM and 1.0 μM, respectively. PBRM1-BD2-IN-2 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
Kd: 9.3 μM (PBRM1-BD2), 10.1 μM (PBRM1-BD5), 18.4 μM (SMARCA2B), 69 μM (SMARCA4)[1]. IC50: 1.0 μM (PBRM1-BD2)[1]. |
| In Vitro | PBRM1-BD2-IN-2 (0, 0.1, 1, and 10 μM; 5 days) selectively inhibit growth of a PBRM1-dependent prostate cancer cell line[1]. PBRM1-BD2-IN-2 has binding affinity for PBRM1-BD2, PBRM1-BD5, SMARCA2B amd SMARCA4 with Kd values of 9.3 μM, 10.1 μM, 18.4 μM and 69 μM, respectively[1]. PBRM1-BD2-IN-2 has inhibitory activity for PBRM1-BD2 with IC50 value of 1.0 μM[1]. Cell Viability Assay[1] Cell Line: Human prostate cell lines LNCaP, PC3, and RWPE-1 Concentration: 0, 0.1, 1, and 10 μM Incubation Time: 5 days Result: Inhibited LNCaP growth at higher concentrations. |
| Molecular Formula | C14H9Cl2FN2O |
|---|---|
| Molecular Weight | 311.14 |